“fibrosis” Archives

in
Entry Author Date Location
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More 10/02/20 National
Galecto Picks Up $64M as Plans for Fibrosis Clinical Trials Move Forward 09/25/20 Europe
Arrowhead Pharma Shares Soar on Early Liver Data for RNAi Drug 09/16/20 Wisconsin
Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More 09/11/20 National
Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More 08/28/20 National
FDA Says “No” to Intercept Pharma’s NASH Drug, Asks for More Data 06/29/20 New York
Frazier Launches Lassen to Advance Antibodies Against Fibrosis, Cancer 06/17/20 San Diego
Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More 06/05/20 National
Pliant Therapeutics Prices IPO, Lands $144M to Test Fibrosis Drugs 06/03/20 San Francisco
Pliant Pushes Forward With IPO Plans to Back Fibrosis Drug Studies 05/12/20 San Francisco
Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More 03/13/20 National
Novartis Leads $100M Round for Fibrosis-Focused Pliant Therapeutics 03/03/20 San Francisco
Bristol-Myers, BioMotiv Pact Leads to a New Fibrosis-Focused Startup 02/04/20 New York
Celgene-Seeded PharmAkea Sells Last Fibrotic Drug Candidate to Galecto 01/07/20 San Diego
Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More 12/13/19 National
With $65M, Cygnal Tunes In to Nerve Signals for Drug-Making Clues 10/08/19 Boston
Bio Roundup: Pelosi’s Reveal, Alder’s Deal, Biogen’s Fails & More 09/20/19 National
Goldfinch Bio Lands $55M From Gilead in Kidney Drug R&D Pact 05/08/19 Boston
After NASH Drug’s 2nd Failure, Gilead Pins Hopes on Combo Therapies 04/25/19 San Francisco
Intercept Touts a Smaller Piece of Its NASH Trial at Liver Conference 04/11/19 New York
NGM Bio’s IPO Raises $107M as NASH Drug Continues Clinical Testing 04/03/19 San Francisco
Bio-JPM Roundup: Lilly Buys Loxo, Sage’s Stock Soars, ALS Cash & More 01/07/19 National
Gilead Sciences Commits $150M to Agenus in Cancer Drug R&D Pact 12/20/18 San Francisco
Gilead, Scholar Rock Sign $80M Up Front Deal for Fibrosis Drugs 12/19/18 Boston
AbbVie Commits $100M to Morphic in Fibrosis Drug R&D Alliance 10/18/18 Boston
Zafgen Exec Thomas Hughes Resigns to Take CEO Job at Navitor 08/02/18 Boston
Fresh Off Bristol Buyout, IFM Backers Raise $31M to Plot a Second Strike 07/19/18 Boston
Pliant Picks Up $62M to Test Lung, Liver Fibrosis Drug in the Clinic 07/16/18 San Francisco
Conatus Pharma’s Liver Disease Drug Flunks First Phase 2 Test 04/05/18 San Diego
Evestra Snags DoD Grant For Experimental Breast Cancer Drug Research 02/22/18 Texas
Page 1 of 2 next page »